Company IR Biosciences Holdings Inc. Other OTC
Equities
IRBS
US46264M3034
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2009 | Weight | 2010 | Weight | Delta |
---|---|---|---|---|---|
Homspera
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Sales per region
USD in Million | 2009 | Weight | 2010 | Weight | Delta |
---|---|---|---|---|---|
United States
nan
%
| 0 | nan % | 0 | nan % | +-NaN% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 30/06/03 | |
John N. Fermanis
DFI | Director of Finance/CFO | 70 | 30/11/04 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | 30/06/03 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 17,082,963 | 17,082,963 ( 100.00 %) | 0 | 100.00 % |
Company contact information
IR Biosciences Holdings, Inc.
8777 East Via de Ventura Suite 280
85258, Scottsdale
+
Sector
1st Jan change | Capi. | |
---|---|---|
+48.67% | 58.71B | |
-2.76% | 41.31B | |
+36.42% | 39.2B | |
-11.22% | 27.4B | |
+9.25% | 26.55B | |
-23.10% | 18.98B | |
+1.88% | 12.51B | |
+26.43% | 12.08B | |
+21.74% | 11.94B |